News

Filter

Current filters:

VelcadeAlkeran

EC approves expanded indication for Velcade

15-09-2008

US health care major Johnson & Johnson's multiple myeloma drug Velcade (bortezomib) has been approved…

AlkeranbortezomibDeltasoneJanssen-CilagJohnson & JohnsonmelphalanPrednisoneVelcade

Millennium publishes results of VISTA trial

08-09-2008

Millennium, now a US subsidiary of Japan's Takeda, has published results from the Phase III VISTA trial…

AlkeranbortezomibDeltasonemelphalanPrednisoneVelcade

Millennium/J&J's FDA approval for Velcade

30-06-2008

The US Food and Drug Administration has given approval to Velcade (bortezomib), an injection for the…

AlkeranAmino AcidsbortezomibDeltasoneInjectionJohnson & JohnsonmelphalanNystatinOralPhysostigmine SalicylatePrednisoneVelcade

Millennium initiates Ph III trial of Velcade

23-07-2007

The USA's Millennium Pharmaceuticals has initiated a randomized, multicenter, Phase III trial to determine…

AlkeranbortezomibDeltasonemelphalanPrednisoneThalidomideThalomidVelcade

Millennium and J&J start Velcade Ph III study

17-01-2005

US companies Millennium Pharmaceuticals and Johnson & Johnson Pharmaceutical R&D have initiated VISTA…

AlkeranbortezomibDeltasoneJohnson & JohnsonmelphalanPrednisoneVelcade

COMPANY SPOTLIGHT

Menarini

Back to top